Authors
Loading...
Retrospective multicenter study reports clinical heterogeneity, frequent BRAF mutations, and varied therapies in adults with Langerhans cell histiocytosis, highlighting the need for standardized care.
Quon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: